Nav: Home

Better patient outcome linked to get with the guidelines-stroke

April 14, 2016

DALLAS, April 14, 2016 -- Stroke patients at hospitals participating in a nationwide quality-improvement program were more likely to be discharged home and less likely to die after discharge than patients in non-participating hospitals, according to new research in the American Heart Association's journal Stroke.

The program, Get With The Guidelines®-Stroke, established by the American Heart Association/American Stroke Association in 2003, helps hospitals provide stroke patients with the latest, most effective treatment for stroke. More than 1,600 hospitals have registered to receive patient-management toolkits, access to workshops, decision support, and many other resources.

"We know that in the past the Get With The Guidelines-Stroke program was associated with improved processes of care, such as appropriate medications and other interventions to prevent complications," said Sarah Song M.D., M.P.H., lead author of the study and an assistant professor in neurology at Rush University Medical Center in Chicago, IL. "Now we know that this improved care translates into improved clinical outcomes."

In this study, stroke patients who received treatment at hospitals participating in Get With The Guidelines-Stroke program were 10 percent more likely than those in non-participating hospitals to be discharged home, rather than to a rehabilitation center or other facility. Furthermore, 30 days and one year after discharge, patients from participating hospitals were 7-8 percent less likely to have died. These findings mean that participating hospitals would discharge 12 more stroke patients home for every 1,000 patients than non-participating hospitals, and 34 fewer patients would have died within one year.

A stroke is a medical emergency that occurs when a blood vessel either bursts or becomes blocked by fatty substances or a blood clot, interrupting blood flow to the brain. Without immediate treatment, cells in the brain begin to die, resulting in brain damage, paralysis, or even death. Warning signs and the necessary response are face drooping; arm or leg weakness or numbness; speech difficulty; time to call 9-1-1, or F.A.S.T.

In the United States, stroke is the fifth-leading cause of death, killing someone about every four minutes.

"By improving the infrastructure for stroke care, the program has been effective, not only in improving measures of process and care, but also clinical outcomes, which is what patients should care about most," Song said. "Stroke patients in hospitals with Get With The Guidelines-Stroke tended to do better, were less likely to die and more likely to go home after hospital discharge."

The study consisted of 173,985 Medicare patients with stroke caused by a blocked blood vessel. Roughly half of participants received treatment at hospitals participating in Get With The Guidelines-Stroke, while the other half was treated at non-participating hospitals. Participants' average age was 79 years, three-fifths were women, and most were white.

Investigators analyzed data from the Centers for Medicare & Medicaid Service for 366 hospitals participating in Get With The Guidelines-Stroke and 366 non-participating hospitals. The study ran from April 1, 2003 to December 1, 2008, data collection began 18 months before participating hospitals' joined the program, and follow-up was up to 18 months after program implementation.

A study limitation is that unforeseen factors could have affected the results, although investigators did match patients and hospitals in terms of their characteristics. In addition, the study did not measure disability after hospital discharge and could not control for whether or not patients followed treatment recommendations after leaving the hospital. This study was also done only in the Medicare population, so only in people aged 65 or older.
Co-authors are Gregg C. Fonarow, M.D.; DaiWai M. Olson, Ph.D., R.N.; Li Liang, Ph.D.; Phillip J. Schulte, Ph.D.; Adrian F. Hernandez, M.D., M.S.; Eric D. Peterson, M.D., M.P.H.; Mathew J. Reeves, Ph.D.; Eric E. Smith, M.D., M.P.H.; Lee H. Schwamm, M.D.; and Jeffrey L. Saver, M.D.

Author disclosures are on the manuscript.

The University of California, Los Angeles; Charles Drew University; Resource Centers for Minority Aging Research Center for Health Improvement of Minority Elderly under NIH/National Institute on Aging Grant P30-AG021684; the UCLA Clinical and Translational Science Institute under NIH/National Center for Advancing Translational Sciences Grant Number UL1TR000124; the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number U54NS081764; and an award to UCLA from the AHA PRT and David and Stevie Spina supported the study. A charitable contribution from Janssen Pharmaceutical Companies of Johnson & Johnson supports, in part, Get With The Guidelines-Stroke (GWTG-Stroke), which is provided by the American Heart Association. In the past, Boeringher-Ingelheim; Merck, Bristol-Myers Squib/Sanofi Pharmaceutical Partnership; and the AHA Pharmaceutical Roundtable supported the program.

Additional Resources:

Researcher photo, stroke graphics, and stroke animation are located in the right column of this release link

After April 14, EMBARGO DATE , view the manuscript online.

Follow AHA/ASA news on Twitter @HeartNews.

For stroke science, follow the Stroke journal at @StrokeAHA_ASA

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at

American Heart Association

Related Stroke Articles:

Retraining the brain to see after stroke
A new study out today in Neurology, provides the first evidence that rigorous visual training restores rudimentary sight in patients who went partially blind after suffering a stroke, while patients who did not train continued to get progressively worse.
Catheter ablations reduce risks of stroke in heart patients with stroke history, study finds
Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation to treat the abnormal heart rhythm lower their long-term risk of a recurrent stroke by 50 percent, according to new research from the Intermountain Medical Center Heart Institute.
Imaging stroke risk in 4-D
A new MRI technique developed at Northwestern University detects blood flow velocity to identify who is most at risk for stroke, so they can be treated accordingly.
Biomarkers may help better predict who will have a stroke
People with high levels of four biomarkers in the blood may be more likely to develop a stroke than people with low levels of the biomarkers, according to a study published in the Aug.
Pre-stroke risk factors influence long-term future stroke, dementia risk
If you had heart disease risk factors, such as high blood pressure, before your first stoke, your risk of suffering subsequent strokes and dementia long after your initial stroke may be higher.
Intervention methods of stroke need to focus on prevention for blacks to reduce stroke mortality
Blacks are four times more likely than their white counterparts to die from stroke at age 45.
Study shows area undamaged by stroke remains so, regardless of time stroke is left untreated
A study led by Achala Vagal, M.D., associate professor at the University of Cincinnati College of Medicine and a UC Health radiologist, looked at a group of untreated acute stroke patients and found that there was no evidence of time dependence on damage outcomes for the penumbra, or tissue that is at risk of progressing to dead tissue but is still salvageable if blood flow is returned in a stroke, but rather an association with collateral flow -- or rerouting of blood through clear vessels.
Immediate aspirin after mini-stroke substantially reduces risk of major stroke
Using aspirin urgently could substantially reduce the risk of major strokes in patients who have minor 'warning' events.
SAGE launches the European Stroke Journal with the European Stroke Organisation
SAGE, a world leading independent and academic publisher, is delighted to announce the launch of the European Stroke Journal, the flagship journal of the European Stroke Organisation.
The S-stroke or I-stroke?
The year 2016 is an Olympic year. Developments in high-performance swimwear for swimming continue to advance, along with other areas of scientific research.

Related Stroke Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...